Role of α-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ETM.2016.3153PMID 27168849PMCID PMC4840563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measures of Injury Severity and Prediction of Acute Traumatic Brain Injury Outcomes

  2015cited by this paper
• Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury.

  2014cited by this paper
• Cytoskeletal protein α-II spectrin degradation in the brain of repeated blast exposed mice.

  2014influential reference
• Brain injury‐induced proteolysis is reduced in a novel calpastatin‐overexpressing transgenic mouse

  2013cited by this paper
• Proteolysis of Submembrane Cytoskeletal Proteins Ankyrin‐G and αII‐Spectrin Following Diffuse Brain Injury: A Role in White Matter Vulnerability at Nodes of Ranvier

  2010cited by this paper
• αII-Spectrin Breakdown Product Cerebrospinal Fluid Exposure Metrics Suggest Differences in Cellular Injury Mechanisms after Severe Traumatic Brain Injury

  2009cited by this paper
• Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways

  2009cited by this paper
• Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury

  2007cited by this paper
• Computed tomography--an increasing source of radiation exposure.

  2007cited by this paper
• Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

  2007cited by this paper
• Better safe than sorry?

  2007cited by this paper
• Neuronal and glial apoptosis in human traumatic brain injury

  2007cited by this paper
• Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.

  2006cited by this paper
• Spectrin breakdown products in the cerebrospinal fluid in severe head injury – preliminary observations

  2005cited by this paper
• Cell Death Mechanisms Following Traumatic Brain Injury

  2004influential reference
• Accumulation of Calpain and Caspase-3 Proteolytic Fragments of Brain-Derived αII-Spectrin in Cerebral Spinal Fluid after Middle Cerebral Artery Occlusion in Rats

  2004cited by this paper
• Effects of Injury Severity on Regional and Temporal mRNA Expression Levels of Calpains and Caspases after Traumatic Brain Injury in Rats

  2004influential reference
• Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis

  2002cited by this paper
• Better safe than sorry

  2002cited by this paper
• Misclassification and Treatment Effect on Primary Outcome Measures in Clinical Trials of Severe Neurotrauma

  2002cited by this paper
• Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats

  2001cited by this paper
• Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

  2001cited by this paper
• Calpain and caspase: can you tell the difference?, by kevin K.W. WangVol. 23, pp. 20-26

  2000cited by this paper
• Calpain and caspase: can you tell the difference?

  2000cited by this paper
• The central effectors of cell death in the immune system.

  1999influential reference
• Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells*

  1998cited by this paper
• Structured Interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for Their Use

  1998influential reference
• Ca(2+)-dependent mechanisms of cell injury in cultured cortical neurons.

  1998cited by this paper
• Immunohistochemical Study of Calpain-Mediated Breakdown Products to α-Spectrin Following Controlled Cortical Impact Injury in the Rat

  1997cited by this paper
• Apoptosis, oncosis, and necrosis. An overview of cell death.

  1995cited by this paper
• Improved confidence of outcome prediction in severe head injury. A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressure.

  1981cited by this paper

• Clinical biomarker potential of spectrin breakdown degradation products: a systematic review.

  2026cites this paper
• Millimeter-Wave Directed Energy-Mediated Neural Cell Injury: Insights into Protein Degradation and Cell Injury Mechanisms

  2025cites this paper
• Biomarkers of neuroinflammation in the diagnosis of traumatic brain injury and neurodegenerative diseases: a literature review

  2024cites this paper
• Traumatic brain injury heterogeneity affects cell death and autophagy

  2024cites this paper
• Unveiling the predictive power of biomarkers in traumatic brain injury: A narrative review focused on clinical outcomes.

  2024cites this paper
• Serum spectrin breakdown product and neurofilament heavy in predicting outcome after cardiac arrest: A diagnostic accuracy study

  2023cites this paper
• Post-mortem detection of neuronal and astroglial biochemical markers in serum and urine for diagnostics of traumatic brain injury

  2023cites this paper
• The role of spectrin breakdown products in patients with traumatic brain injury: a systematic review and meta-analysis

  2022cites this paper
• Comparing blood biomarkers to clinical decision rules to select patients suspected of traumatic brain injury for head computed tomography

  2022cites this paper
• The prognostic significance of biomarkers in cerebrospinal fluid following severe traumatic brain injury: a systematic review and meta-analysis

  2022cites this paper
• Sirtuins, a potential target in Traumatic Brain Injury and relevant experimental models.

  2021cites this paper
• The role of autoimmunity after traumatic brain injury

  2020cites this paper
• Genetic Modulators of Traumatic Brain Injury in Animal Models and the Impact of Sex-Dependent Effects

  2020cites this paper
• Biomarkers in traumatic brain injury: new concepts

  2020cites this paper
• Current Trends in Biomarkers for Traumatic Brain Injury.

  2020cites this paper
• Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial

  2020cites this paper
• Clinical significance of detecting serum melatonin and SBDPs in brain injury in preterm infants.

  2019cites this paper
• Biomarkers in acute brain trauma: A narrative review

  2019cites this paper
• Proteomics Analysis Reveals the Implications of Cytoskeleton and Mitochondria in the Response of the Rat Brain to Starvation

  2019cites this paper
• Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post—Traumatic brain injury

  2018cites this paper
• Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.

  2018cites this paper
• Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and αII-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats

  2018cites this paper
• Prognostic utility of neuroinjury biomarkers in post out-of-hospital cardiac arrest (OHCA) patient management.

  2017cites this paper
• Activation and expression of μ-calpain in dorsal root contributes to RTX-induced mechanical allodynia

  2017cites this paper
• Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.

  2017cites this paper
• SBDPs and Tau proteins for diagnosis and hypothermia therapy in neonatal hypoxic ischemic encephalopathy

  2016cites this paper